text
"['\nXII. 상세표\n1. 연결대상 종속회사 현황(상세)\n☞ 본문 위치로 이동\n(단위 : 백만원)\n상호\n설립일\n주소\n주요사업\n최근사업연도말자산총액\n지배관계 근거\n주요종속회사 여부\n동아제약(주)\r\n2013.03.04\n서울 동대문구 천호대로 64\n의약품 제조 및 판매\n331,439\n기업 의결권의 과반수 소유(K-IFRS 제1110호 문단 5부터 18까지)\n주요종속회사(직전사업연도말 자산총액 750억 이상)\n에스티젠바이오(주)\n2015.04.01\n인천광역시 연수구지식기반로 45\n의약품 제조 및 판매\n143,551\n〃\n주요종속회사(직전사업연도말 자산총액 750억 이상)\n(주)수석\n1969.09.01\n경기도 안양시 만안구 박달로 313\n병유리 제조 및 판매\n162,920\n〃\n주요종속회사(직전사업연도말 자산총액 750억 이상)\n용마로지스(주)\r\n1979.02.01\n경기도 김포시고촌읍 아라육로 78\n운수창고업\n235,900\n〃\n주요종속회사(직전사업연도말 자산총액 750억 이상)\nDA인포메이션(주)\r\n2006.06.21\n서울 동대문구천호대로 3\nIT 솔루션\n4,496\n〃\n-\n(주)아벤종합건설\r\n2013.08.22\n경기도 안양시만안구 안양로 552\n건설업\n19,882\n〃\n-\n(주)인더스파크\r\n2010.03.16\n충청남도 당진시합덕읍 예덕로 106\n산업단지개발사업\n14,120\n〃\n-\n동천수(주)\r\n2014.07.03\n경상북도 상주시 화북면문장로 1623-32\n생수제조 및 판매\n78,738\n〃\n-\n디에스프론티어(주)\r\n2017.12.12\n경기도 용인시 기흥구금화로 105번길 21\n타 회사 지분 인수,경영관리업\n7,843\n〃\n-\n(주)얼수\n2022.03.18\n경상북도 상주시 화북면 문장로 1623-32\n농산물 유통판매업\n440\n〃\n-\n용인기흥PFV(주)\n2023.07.04\n서울특별시 동대문구 무학로25길 16, 5층\n부동산개발\n4,670\n〃\n-\n주) 용인기흥PFV(주)는 당기 중 종속기업으로 편입되었습니다.\n2. 계열회사 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 12월 31일\n)\n(단위 : 사)\n상장여부\n회사수\n기업명\n법인등록번호\n상장\n4\n동아쏘시오홀딩스(주)\n110111-0017990\n동아에스티(주)\n110111-5079713\n에스티팜(주)\n154511-0039704\nNeurobo Pharmaceuticals Inc\n해외법인\n비상장\n26\n동아제약(주)\n110111-5079739\n에스티젠바이오(주)\n120111-0756728\n(주)수석\n110111-0107973\n용마LOGIS(주)\n110111-0245369\n디에이인포메이션(주)\n110111-3479478\n(주)인더스파크\n165011-0030519\n(주)아벤종합건설\n130111-0013522\n동아오츠카(주)\n134111-0007761\n(주)동천수\n171411-0019799\n디에스프론티어(주)\n134511-0342771\n동아참메드(주)\n135111-0074206\n(주)얼수\n171411-0032874\n용인기흥PFV(주)\n110111-8682646\n앱티스(주)\n110111-6134722\nNeon Global co., Ltd.\n해외법인\nDong-A America Corp.\r\n〃\n소주동아음료\n〃\nJ Box co., Limited\n〃\nScion Global co., Limited\n〃\nSTP America research Corp\n〃\nCHAMMED(TIANJIN) COMMERCIAL., LTD.\n〃\nANAPATH SERVICES\n〃\nANAPATH RESEARCH\n〃\nLevatio Therapeutics, LLC.\n〃\nDong-A ST India Pvt.\n〃\nVernagen\n〃\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n동아에스티\n상장\n2013.03.04\n경영참가\n192,723\n2,008,140\n23.31\n192,607\n0\n0\n-12,208\n2,008,140\n23.31\n180,399\n1,264,421\n2,021\n에스티팜\n상장\n2010.06.10\n경영참가\n3,500\n6,096,552\n32.41\n209,762\n0\n0\n0\n6,096,552\n32.41\n209,762\n570,652\n17,516\n동아제약\n비상장\n2013.03.04\n경영참가\n39,844\n6,000,000\n100.00\n39,844\n0\n0\n0\n6,000,000\n100.00\n39,844\n349,945\n63,903\n용마로지스\n비상장\n1984.07.18\n경영참가\n49\n1,660,000\n100.00\n24,055\n0\n0\n0\n1,660,000\n100.00\n24,055\n308,617\n7,556\n수석\n비상장\n1974.07.18\n경영참가\n30\n2,000,000\n100.00\n57,182\n0\n0\n0\n2,000,000\n100.00\n57,182\n229,873\n3,782\n동천수\n비상장\n2014.07.03\n경영참가\n8,000\n1,600,000\n100.00\n43,678\n0\n0\n0\n1,600,000\n100.00\n43,678\n109,791\n509\n디에이인포메이션\n비상장\n2006.06.21\n경영참가\n1,157\n231,464\n100.00\n1,562\n0\n0\n0\n231,464\n100.00\n1,562\n4,926\n966\n아벤종합건설\n비상장\n2017.08.25\n경영참가\n10,390\n340,000\n100.00\n10,390\n0\n0\n0\n340,000\n100.00\n10,390\n29,063\n4,077\n디에스프론티어\n비상장\n2017.12.12\n경영참가\n7,800\n2,282,000\n100.00\n8,382\n0\n0\n0\n2,020,000\n100.00\n8,382\n7,845\n2\n동아오츠카\n비상장\n1979.01.01\n경영참가\n1,793\n6,598,160\n49.99\n36,842\n0\n0\n0\n6,598,160\n49.99\n36,842\n260,389\n22,685\n에스티젠바이오\n비상장\n2015.04.01\n경영참가\n104\n3,055,200\n80.40\n116,211\n0\n0\n-10,861\n1,938,000\n80.40\n105,350\n155,071\n-8,782\n한국신동공업\n비상장\n1984.04.19\n경영참가\n70\n300,000\n30.00\n4,011\n0\n0\n0\n300,000\n30.00\n4,011\n30,415\n1,486\nNeon Global co., Ltd.\n비상장\n2014.08.29\n경영참가\n2,026\n1,686,201\n45.00\n2,026\n0\n0\n0\n1,686,201\n45.00\n2,026\n9,858\n482\n크리컴\n비상장\n1974.02.26\n단순투자\n75\n150,000\n25.00\n355\n-150,000\n-355\n0\n0\n0.00\n0\n0\n0\nLevatio Therapeutics, LLC.\n비상장\n2021.07.29\n단순투자\n0\n1,000,000\n31.67\n1,155\n0\n0\n0\n1,000,000\n22.50\n1,155\n713\n-2,129\n아시아허브PFV\n비상장\n2023.06.14\n단순투자\n1,200\n0\n0.00\n0\n240,000\n1,200\n0\n240,000\n20.00\n1,200\n5,964\n-465\n용인기흥PFV\n비상장\n2023.07.04\n단순투자\n4,500\n0\n0.00\n0\n900,000\n4,500\n0\n900,000\n90.00\n4,500\n4,670\n-330\nBBROS\n비상장\n2018.12.21\n단순투자\n2,000\n53,232\n1.85\n67\n0\n0\n0\n53,232\n1.85\n67\n10,007\n-5,526\n멥스젠\n비상장\n2022.07.08\n단순투자\n2,000\n5,935\n2.84\n2,000\n0\n0\n0\n5,935\n2.84\n2,000\n5,942\n-3,999\n아이티켐\n비상장\n2022.09.16\n단순투자\n2,000\n6,445\n1.36\n2,000\n0\n0\n0\n6,445\n1.26\n2,000\n63,657\n1,255\nOric Pharmaceuticals\n상장\n2018.02.09\n단순투자\n1,313\n116,667\n0.33\n871\n-116,667\n-871\n0\n0\n0.00\n0\n0\n0\nOtsuka Holdings\n상장\n2010.12.17\n단순투자\n3,585\n125,000\n0.02\n5,129\n0\n0\n905\n125,000\n0.02\n6,034\n3,102,716\n137,419\n합 계\n-\n-\n758,129\n873,333\n4,474\n-22,164\n-\n-\n740,439\n-\n-\n']"
